Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients

Table 1 Baseline characteristics of 11385 genotype 1b-infected patients treated with interferon-free regimens

Parameter	GT1b patients, n = 11385
Sex, female/male, n (%)	6085 (53.4)/5300 (46.6)
Age in yr, mean ± SD; min-max	53 ± 14.8; 17-97
Females	54.8 ± 15.1; 18-92
Males	51 ± 14.3; 17-97
BMI, kg/m2 mean ± SD; min-max	26.3 ± 4.5; 13.2-57.4
Comorbidities, n (%)
Any comorbidity	7280 (63.9)
Hypertension	4013 (35.2)
Diabetes	1447 (12.7)
Renal disease	470 (4.1)
Autoimmune diseases	251 (2.2)
Non-HCC tumors	237 (2.1)
Other	5330 (46.8)
Concomitant medications, n (%)	6842 (60.1)
Liver fibrosis n(%)
F0	237 (2.1)
F1	4440 (39)
F2	2135 (18.8)
F3	1587 (13.9)
F4	2768 (24.3)
No data	218 (1.9)
HCC history, n (%)	175 (1.5)
OLTx history, n (%)	122 (1.1)
HBV coinfection (HBsAg+), n (%)	106 (0.9)
HIV coinfection, n (%)	359 (3.1)
ALT IU/L, mean ± SD	75.8 ± 65.5
Bilirubin mg/dL, mean ± SD	0.8 ± 0.9
Albumin g/dL, mean ± SD	4.3 ± 3.2
Creatinine mg/dL, mean ± SD	0.9 ± 1.8
Hemoglobin g/dL, mean ± SD	14.4 ± 1.8
Platelets × 1000/μL, mean ± SD	195.3 ± 77.8
HCV RNA × 106 IU/mL, mean ± SD	2.1 ± 4.7

ALT: Alanine transaminase; BMI: Body mass index; F: Fibrosis; GT: Genotype; HBsAg+: Hepatitis B surface antigen; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus; IFN: Interferon; OLTx: Orthotopic liver transplantation; SD: Standard deviation.